{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-24-000264","form_type":"8-K","ticker":"ARCT","cik":"0001768224","company_name":"Arcturus Therapeutics Holdings Inc.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.456628+00:00","generated_at":"2026-06-05T17:16:11.740502+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Arcturus Therapeutics controller resigns effective March 15, 2024; assistant controller promoted","bullets":["Keith C. Kummerfeld, SVP of Finance and Corporate Controller, resigns effective March 15, 2024 to pursue another opportunity.","Joseph Roberts, formerly Assistant Controller, promoted to Controller of the Company.","Resignation is not due to any disagreement with the Company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-24-000264","json":"https://secwatch.observer/filing/0001193805-24-000264.json","markdown":"https://secwatch.observer/filing/0001193805-24-000264.md","text":"https://secwatch.observer/filing/0001193805-24-000264.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/0001193805-24-000264-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/e619292_8k-arct.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T17:16:11.740502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"564d9ed4e1","claim":"Joseph Roberts changed role as Controller at Arcturus Therapeutics Holdings Inc..","evidence_excerpt":"Joseph Roberts, formerly the Company’s Assistant Controller, has been promoted to Controller of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/0001193805-24-000264-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Controller"}],"fact_type":"executive_change"},{"claim_id":"7fd14ad2c4","claim":"Keith C. Kummerfeld resigned as Senior Vice President of Finance and Corporate Controller at Arcturus Therapeutics Holdings Inc..","evidence_excerpt":"Keith C. Kummerfeld, Senior Vice President of Finance and Corporate Controller of Arcturus Therapeutics Holdings Inc. (the “Company” or “Arcturus”), informed the Company that he will resign from his position with the Company, effective March 15, 2024, to pursue another opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000264/0001193805-24-000264-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Senior Vice President of Finance and Corporate Controller"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}